Patent · US Expired

Transdermal systems for release of 5-HT3 receptor antagonists and their use in anti-emetic treatment

US6440453B1 · kind B1 · utility

7Cited by

4References

21Claims

0Family size

Assignee

Novosis Pharma AG · DE

Inventors

Wilfried Fischer · Holzkirchen, DE
Axel Stierle · Munich, DE

Key dates

Filing date	Jun 23, 2000
Grant date	Aug 27, 2002
Priority date	—
Expiry date	Jun 24, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention refers to a transdermal system for release of 5-HT3 receptor antagonists which is characterized in that it contains a composition of a 5-HT3 receptor antagonist as an active agent, tea tree oil, a water-miscible solvent and water.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.